Atsushi Kiba
Publications by Year
Research Areas
Cancer, Lipids, and Metabolism, Prostate Cancer Treatment and Research, Cancer, Hypoxia, and Metabolism, Hypothalamic control of reproductive hormones, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma(2018)138 cited
- → VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice(2003)96 cited
- → Interleukin-6 and Oncostatin-M Synergize with the PI3K/AKT Pathway to Promote Aggressive Prostate Malignancy in Mouse and Human Tissues(2013)55 cited
- → Chimeric VEGF-E NZ7 /PlGF Promotes Angiogenesis Via VEGFR-2 Without Significant Enhancement of Vascular Permeability and Inflammation(2006)46 cited
- → A Set of Loop-1 and -3 Structures in the Novel Vascular Endothelial Growth Factor (VEGF) Family Member, VEGF-ENZ-7, Is Essential for the Activation of VEGFR-2 Signaling(2003)44 cited
- → Synthesis and structure–activity relationships of 2-acylamino-4,6-diphenylpyridine derivatives as novel antagonists of GPR54(2010)32 cited
- → 2-Acylamino-4,6-diphenylpyridine derivatives as novel GPR54 antagonists with good brain exposure and in vivo efficacy for plasma LH level in male rats(2010)32 cited
- → Pharmacologic profiles of investigational kisspeptin/metastin analogues, TAK-448 and TAK-683, in adult male rats in comparison to the GnRH analogue leuprolide(2014)31 cited
- → Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH2(TAK-448), with Highly Potent Testosterone-Suppressive Activity and Excellent Water Solubility(2016)29 cited
- → Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 2: Benzimidazole-5-sulfonamides(2004)24 cited